KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $25.5 million.

  • Medpace Holdings' Other Working Capital Changes fell 2145.32% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.4 million, marking a year-over-year increase of 736.28%. This contributed to the annual value of $150.7 million for FY2024, which is 5517.7% up from last year.
  • Per Medpace Holdings' latest filing, its Other Working Capital Changes stood at $25.5 million for Q3 2025, which was down 2145.32% from $80.6 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Other Working Capital Changes ranged from a high of $80.6 million in Q2 2025 and a low of -$15.0 million during Q1 2023
  • Its 5-year average for Other Working Capital Changes is $27.9 million, with a median of $28.2 million in 2023.
  • Per our database at Business Quant, Medpace Holdings' Other Working Capital Changes soared by 29567306.19% in 2022 and then crashed by 23420973.89% in 2023.
  • Over the past 5 years, Medpace Holdings' Other Working Capital Changes (Quarter) stood at $40.8 million in 2021, then rose by 9.83% to $44.8 million in 2022, then decreased by 8.25% to $41.1 million in 2023, then dropped by 3.55% to $39.6 million in 2024, then tumbled by 35.57% to $25.5 million in 2025.
  • Its last three reported values are $25.5 million in Q3 2025, $80.6 million for Q2 2025, and $17.6 million during Q1 2025.